Supply Chain

Multiple locations in Mexico and Brazil can now be served more quickly

Three more locations join continents

Company touts 12 months of rapid growth

The advantages of aligning patient recruitment and supply data

Walgreens is one of the retailers joining in the testing program

Regulation enables better coordination of where opioids are going

The goal of producing meaningful data is driving industry progress

Issues include apparently diverted opioids and mislabeled medications

As the definition of ‘targeted’ therapies—especially in oncology—and as a component of companion diagnostics, biomarkers are creating opportunities in drug research and commercialization

30-day deadline for making an application to participate; in the EU, the FMD program is progressing

A marketing challenge: how to make more adults aware of anti-bacterial booster shots

Expansions in the capability of supply chain participants to manage temperature-controlled pharmaceuticals

Even as the science behind the new therapies is getting established, payers are preparing for their extraordinary cost

Broader capabilities for refrigerated or cryogenic transport of cellular materials

Field trial results to be unveiled at upcoming meeting

Partnership with Dacos A/S; FDA will look closer at cellular and genetic therapies

List includes 25 orphan drugs; there were also seven additional biosimilars

Flu activity is “elevated” nationally; Walgreens sees a hotspot in Nebraska

Nearly a million US citizens live with HIV, a virus that still lacks a curative therapy

Cellular and genetic therapies (CGTs) developers are struggling to build capacity

Oncology represents half of the dollar volume of HDA-member sales

Action consolidates leading courier companies with larger freight forwarders

Sales volume handled by primary wholesaler/distributors seems to be declining

The carbon footprint of shipping alternatives is also becoming a competitive issue